Prospective evaluation of an assessment tool for technical performance of duodenoscopes

Ji Young Bang, Thomas Rösch, Hyungjin Myra Kim, Shyam Thakkar, Ernesto Robalino Gonzaga, Benjamin Tharian, Sumant Inamdar, Linda S Lee, Patrick Yachimski, Priya Jamidar, Thiruvengadam Muniraj, Christopher DiMaio, Nikhil Kumta, Amrita Sethi, Peter Draganov, Dennis Yang, Talal Seoud, Abhilash Perisetti, Gayatri Bondi, Sachin Kirtane, Robert Hawes, C Mel Wilcox, Richard Kozarek, D Nageshwar Reddy, Shyam Varadarajulu, Ji Young Bang, Thomas Rösch, Hyungjin Myra Kim, Shyam Thakkar, Ernesto Robalino Gonzaga, Benjamin Tharian, Sumant Inamdar, Linda S Lee, Patrick Yachimski, Priya Jamidar, Thiruvengadam Muniraj, Christopher DiMaio, Nikhil Kumta, Amrita Sethi, Peter Draganov, Dennis Yang, Talal Seoud, Abhilash Perisetti, Gayatri Bondi, Sachin Kirtane, Robert Hawes, C Mel Wilcox, Richard Kozarek, D Nageshwar Reddy, Shyam Varadarajulu

Abstract

Objective: While single-use and detachable-tip duodenoscopes have been recently developed to overcome risks of infection transmission, there are no reliable tools to objectively assess their technical performance. We evaluated the reliability and validity of a newly developed tool to assess the technical performance of reusable duodenoscopes.

Methods: An assessment tool was developed to measure duodenoscope performance based on three distinct criteria: maneuverability, mechanical/imaging characteristics and ability to perform requisite interventions. The assessment tool was tested prospectively on duodenoscopes used in endoscopic retrograde cholangiopancreatography (ERCP) procedures at nine academic medical centers over a 6-month period. The main outcome was reliability of the duodenoscope assessment tool, which was estimated using Cronbach's coefficient alpha (α). The secondary outcome was validity of the assessment tool.

Results: The assessment tool evaluated technical performance of reusable duodenoscopes in 1080 ERCP procedures. Indications were biliary in 92.8% and pancreatic in 7.2% procedures. The overall Cronbach's coefficient α for maneuverability was 0.81, assessment of mechanical/imaging characteristics was 0.92, and ability to perform requisite interventions was 0.87. On multiple linear regression analysis, prolonged procedure duration, older patient age and pancreatic interventions were significantly positively associated with higher (worse) scores.

Conclusions: The newly developed assessment tool appears reliable and valid for evaluating the technical performance of duodenoscopes. Registration: ClinicalTrials.gov Identifier: NCT04004533.

Keywords: duodenoscope; duodenoscope assessment tool; endoscopic retrograde cholangiopancreatography.

© 2020 Japan Gastroenterological Endoscopy Society.

References

    1. Varadarajulu S, Kilgore ML, Wilcox CM et al. Relationship among hospital ERCP volume, length of stay, and technical outcomes. Gastrointest Endosc 2006; 64: 338-47.
    1. Domagk D, Oppong KW, Aabakken L et al. Performance measures for endoscopic retrograde cholangiopancreatography and endoscopic ultrasound: A European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. United Eur Gastroenterol J 2018; 6: 1448-60.
    1. Meagher S, Yusoff I, Kennedy W et al. The roles of magnetic resonance and endoscopic retrograde cholangiopancreatography (MRCP and ERCP) in the diagnosis of patients with suspected sclerosing cholangitis: a cost-effectiveness analysis. Endoscopy 2007; 39: 222-8.
    1. Irabaa SF, Nguyen P, Sanderson R et al. Early identification and control of carbapenemase-producing Klebsiella pneumoniae, originating from contaminated endoscopic equipment. Am J Infect Control 2013; 41: 562-4.
    1. Epstein L, Hunter JC, Arwady MA et al. New Delhi metallo-β-lactamase-producing carbapenem-resistant escherichia coli associated with exposure to duodenoscopes. JAMA 2014; 312: 1447-55.
    1. FDA recommends health care facilities and manufacturers begin transitioning to duodenoscopes with disposable components to reduce risk of patient infection. Available from URL: . January 17, 2020.
    1. Huang RJ, Barakat MT, Girotra M et al. Unplanned hospital encounters after endoscopic retrograde cholangiopancreatography in 3 large North American States. Gastroenterology 2020; 156: 119-29.e3.
    1. Lail LM, Cotton PB. Risks of endoscopic retrograde cholangiopancreatography and therapeutic applications. Gastroenterol Nurs 1990; 12: 239-45.
    1. Muthusamy VR, Bruno MJ, Kozarek RA et al. Clinical evaluation of a single-use duodenoscope for endoscopic retrograde cholangiopancreatography. Clin Gastroenterol Hepatol 2020; 18: 2108-17.e3.
    1. FDA clears first duodenoscope with disposable distal cap. Available from URL: . September 20, 2017.
    1. Aaronson NK, Ahmedzai S, Bergman B et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-76.
    1. Bloechle C, Izbicki JR, Knoefel WT et al. Quality of life in chronic pancreatitis-results after duodenum-preserving resection of the head of the pancreas. Pancreas 1995; 11: 77-85.
    1. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297-334.
    1. Bland JM, Altman DG. Cronbach’s alpha. BMJ 1997; 314: 572.
    1. Streiner DL. Starting at the beginning: An introduction to coefficient alpha and internal consistency. J Pers Assess 2003; 80: 99-103.
    1. Taber KS. The use of Cronbach's alpha when developing and reporting research instruments in science education. Res Sci Educ 2018; 48: 1273-96.
    1. Navaneethan U, Hasan MK, Kommaraju K et al. Digital, single-operator cholangiopancreatoscopy in the diagnosis and management of pancreatobiliary disorders: a multicenter clinical experience (with video). Gastrointest Endosc 2016; 84: 649-55.
    1. Cohen DL, Naik JR, Tamariz LJ et al. The perception of gastroenterology fellows towards the relationship between hand size and endoscopic training. Dig Dis Sci 2008; 53: 1902-9.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren